| ACT | asthma control test |
| ADMA | asymmetric dimethyl arginine |
| AS | atherosclerosis |
| BMI | body mass index |
| CF | cystic fibrosis |
| COPD | chronic obstructive pulmonary disease |
| CVD | cardiovascular disease |
| ECP | eosinophil cationic protein |
| ED | endothelial dysfunction |
| FENO | fractional exhaled nitric oxide |
| FEF25-50 | the forced expiratory flow between 25 and 50% of the forced vital capacity |
| FMD | flow-mediated dilatation |
| HI | healthy individuals |
| hsCRP | high-sensitive C-reactive protein |
| ICS | inhaled corticosteroids |
| IgE | immunoglobulin E |
| sIgE | specific immunoglobulin E |
| LABA | long-acting beta-agonist |
| LAMA | long-acting muscarinic antagonist |
| LTRA | leukotriene receptor antagonist |
| NO | nitric oxide |
| OCS | oral corticosteroid |
| OMA | omalizumab |
| PAT | peripheral arterial tone |
| RHI | reactive hyperemia index |
| TPH | theophylline |
| VCAM-1 | vascular cells adhesive molecule |
| VEGF | vascular endothelial growth factor |